Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126346 · ClinicalTrials.gov registry record · NA
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01126346 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants.
The verdict
NCT01126346, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
RATIONALE: An orientation and patient education program and telephone counseling may help improve the quality of life in patients with peritoneal surface malignancies. PURPOSE: This clinical trial studies quality of life and survivorship care in patients undergoing surgery and chemotherapy for peritoneal surface malignancies.
Interventions
- OTHER Questionnaires
- BEHAVIORAL HIPEC Orientation
- BEHAVIORAL Consultation with Survivorship Navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01126346
The ClinicalTrials.gov registry entry for NCT01126346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT01126346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01126346 about?
NCT01126346 is a clinical study titled "Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)". RATIONALE: An orientation and patient education program and telephone counseling may help improve the quality of life in patients with peritoneal surface malignancies. PURPOSE: This clinical trial studies quality of life and survivorship care in patients undergoing surgery and chemotherapy for peri...
What is the current status of trial NCT01126346?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2010-05. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01126346?
The interventions under investigation include: Questionnaires (OTHER), HIPEC Orientation (BEHAVIORAL), Consultation with Survivorship Navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT01126346?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.